Top Social Impact Companies (7,255)

Strong Revenue Growth: Revenue is rising at double-digit rates across multiple periods, including about 26% in 2025 and 22% year over year in Q2 2026. Multi-year gains in direct revenue alongside an expanding payer base reinforce the trajectory.

Market Expansion: International rollout across Europe and Latin America is accelerating, with European expansion‑market revenue up 86% year over year in Q2 2026 and new country launches continuing. Global monthly active users also increased 13% year over year, supporting the geographic scaling.

Resilient & Sustainable Growth: Growth spans users, payers, and revenue, with three successive years of higher direct revenue and a rising paying‑user base. These concurrent trends indicate momentum that extends beyond price mix alone.

Strong Revenue Growth: Sustained strong revenue growth over many years and independent reporting of significant revenue scale point to solid momentum, though the most recent growth rate is undisclosed.

Market Expansion: A larger global customer footprint and the opening of a London office indicate expanding geographic reach and market penetration.

Investor Backing & Capital Strength: A strategic majority investment from a major private equity firm and a reported exploration of a high-value sale underscore access to capital and investor confidence.

Market Expansion: Operations span all 50 states and Washington, D.C., with coverage reported across 100+ health plans and expansion into Medicare Advantage and Medicaid. This broadened payer and geographic footprint increases addressable demand and distribution leverage.

Product Line Growth: Offerings have expanded beyond matching into EHR, AI‑assisted notes, telehealth, billing, integrated‑care referrals, and a patient app. These additions deepen provider engagement and create more touchpoints for utilization and scale.

Strong Revenue Growth: Annual revenue is described as having more than doubled over a recent 12‑month period in 2024, indicating accelerating commercial momentum. While later‑period figures are not disclosed, the earlier surge aligns with rapid operating scale increases.

Investor Backing & Capital Strength: A $30 million Series B led by Andreessen Horowitz in February 2025 brought total funding to $50 million, with Axios independently reporting the round. This capital base supports continued hiring and expansion across product and go-to-market functions.

Market Expansion: The company reports expanding from behavioral health/ABA into physical therapy, ENT/allergy, and broader specialty care, and now serves 500+ providers across all 50 states. Year-end 2025 metrics also cite 81.8% growth in clinics and 163% growth in patients, and a 2026 acquisition added workflow automation expertise.

Innovation-Driven Growth: Platform capabilities are built on more than $2.5 billion in claims data with millions of claims processed, and reported a 12.3% year-over-year improvement in first-pass paid rate. These data- and automation-led workflows underpin scaling of claims across a nationwide footprint.

Strong Revenue Growth: ARR is estimated at $68M by May 2026, up from $55M at end-2025 and $21M in 2024, indicating rapid scaling. Multi-year increases suggest momentum across recurring subscriptions.

Profitability: Company communications and third-party research indicate the business reached profitability by 2025–2026 alongside improving free cash flow and plans to expand hiring. This points to growth supported by operating discipline rather than solely external financing.

Product Line Growth: The platform has expanded beyond community hosting into courses, events, payments, email marketing, websites, branded apps, and AI tools. This broader offering is designed to raise revenue per customer and attract a wider range of organizations.

Market Expansion: Reported service coverage grew from 14 states in 2023 to 20+ states by April 2025, with external reporting also noting expansion beyond Georgia into many additional states. This broader footprint is reinforced by thousands of completed service requests and patients served by 2025.

Innovation-Driven Growth: A granted platform patent in May 2025 and a new transportation partner workflow effective May 1, 2026 indicate continued investment in the core technology. Recognition as a 2025 Technology Association of Georgia Top 10 Innovative Company further supports momentum in product development.

Strategic Partnerships: Launches within Emory Healthcare—extending from an emergency department rollout to Emory Rehabilitation Hospital—demonstrate expansion inside a major health system. Such deployments suggest traction beyond individual clinics.

Market Expansion: Service availability is described across all 50 states with new local launches and roles dedicated to opening regional provider partnerships. This points to broadening geographic reach and distribution through healthcare and senior-care channels.

Product Line Growth: The platform has expanded beyond therapy to include healthcare advocacy, wellness classes, and AI-enabled care agents. These additions indicate a widening offering to address aging-related needs.

Strong Hiring & Retention: Active recruitment spans engineering, operations, analytics, revenue-cycle management, and provider-partnerships to scale care delivery. Such hiring momentum suggests investment in internal capacity to support larger patient and provider volumes.

Profitability: Reported net income rose materially in 2024 alongside stronger mortgage and securities‑based lending activity. Company reports indicate earnings momentum continued into 2025.

Market Expansion: Announced and opened full‑service branches in Boston’s Seaport, Falmouth, and Andover in 2026 indicate deliberate investment in new local markets. Additional hiring of private‑banking and nationwide SBA teams points to geographic and channel expansion.

Investor Backing & Capital Strength: Reported capital ratios are well above regulatory well‑capitalized thresholds, and a long‑running five‑star safety rating is cited. These indicators suggest capacity to fund growth while maintaining buffers.

Future-Ready Strategy: Work on FedNow, technology modernization, and the assignment to host the Credit Risk Management Support Office point to preparation for evolving payments and risk-management needs. These developments indicate a strategic orientation toward modern infrastructure and broader systemwide responsibilities.

Strong Hiring & Retention: Budgeted staffing for 2025 was higher than 2024 actual headcount, signaling planned capacity expansion. Descriptions of long-term operational continuity and retention-focused employment practices reinforce a stable employer profile.

Innovation-Driven Growth: Expansion of the Bank’s digital research footprint, new data tools, and ongoing publication of indices such as the CFNAI and NFCI reflect growth through analytical innovation. These additions broaden data capabilities and public-facing insights.

Strong Revenue Growth: A sixfold year-over-year revenue increase was reported in May 2025, indicating rapid commercial momentum. Rising visit volumes from roughly 5,000 in 2022 to 125,000+ in 2025 further reinforce this trajectory.

Market Expansion: Operations expanded from five states in 2023 to 18 by May 2025 and to nearly 25 states by February 2026. Coverage increasingly spans Medicare, Medicaid, and Marketplace populations, widening the addressable market.

Investor Backing & Capital Strength: A $55 million Series B in May 2025 brought total funding above $125 million, led by prominent investors. This capital base supports ongoing technology, staffing, and multistate rollout.

Strong Hiring & Retention: Hiring is active across sales, account management, product, operations, HR, and compliance, with current postings and updates indicating continued team expansion in 2026. Reported headcount has increased over recent years, pointing to investment in both go-to-market and delivery capacity.

Market Expansion: Operations span numerous U.S. cities and European hubs beyond the company’s original New York base. Materials also describe global retrieval capabilities supported by partners.

Product Line Growth: Services have expanded to include retrievals for laptops, phones, tablets, monitors, and other equipment. A software platform for asset tracking, workflow automation, and compliance reporting broadens the offering further.

Innovation-Driven Growth: Multiple AI-powered safety capabilities launched in 2025–2026, along with incident-management enhancements like QR code reporting, indicate active product investment and an expanding roadmap. These moves support a growth-oriented strategy aimed at deepening platform value.

Strong Market Position & Advantage: Independent analyst recognition as a market Leader across consecutive years and broad category visibility point to durable competitive standing. Such external validation aligns with meaningful market presence and enterprise relevance.

Investor Backing & Capital Strength: A significant minority investment alongside ongoing transaction interest underscores access to capital and confidence in priorities like international expansion, AI development, and acquisitions. This backing supports continued scaling initiatives.

Investor Backing & Capital Strength: A roughly $250 million investment from TPG’s Rise Funds in March 2026 is described as supporting platform expansion, technology upgrades, and meeting growing demand. This level of capital indicates institutional confidence, even if it does not by itself prove revenue or profit.

Market Expansion: Adoption spans all 50 states with 800–1,000+ customers, statewide launches (e.g., TennCare and New Mexico), and a nationwide network reported at over one million program locations and 70M+ users. These deployments signal growing reach across healthcare and government sectors.

Product Line Growth: Acquisitions such as Uno Health (benefits eligibility and enrollment) and Kiip, along with partnerships like SimplePractice, broaden capabilities beyond core referrals into behavioral health access and eligibility workflows. This diversification expands the addressable market and deepens use cases.

Innovation-Driven Growth: Feedback suggests the company is expanding its platform with AI-powered dubbing and an accessibility auditing tool (Pulse), broadening its product scope and capabilities.

Market Expansion: Feedback suggests a 2025 rebrand positioned the firm as a global video solutions provider with services in 50+ languages, indicating efforts to reach international audiences and new segments.

Strategic Partnerships: Feedback suggests private equity backing from Riverside Partners and acquisitions of Captionmax and National Captioning Canada have supported scaling and broader market presence.

Strong Revenue Growth: Feedback suggests ARR reportedly doubled year over year and was expected to at least double again, signaling rapid top-line momentum. While company-reported rather than audited, this is the clearest quantitative indicator provided.

Strong Market Position & Advantage: Feedback suggests adoption across more than 5,000 childcare programs and nationwide reach indicate meaningful scale and positioning. The September 2026 acquisition by Procare further underscores strategic relevance within the category.

Innovation-Driven Growth: Feedback suggests expansion from communications into billing, payroll, enrollment, reporting, subsidy management, and AI tools is broadening the platform’s value proposition. Frequent releases and a childcare-focused AI assistant point to ongoing product-led growth.

Strong Revenue Growth: Feedback suggests revenue expanded rapidly, highlighted by a first-place ranking in the FT’s 2026 Americas’ Fastest-Growing Companies based on 2021–2024 growth and a reported $617.4M in 2024 revenue. Additional signals include reported surges in appointments and broader commercial activity across 2025–2026.

Investor Backing & Capital Strength: Feedback suggests substantial access to capital, including a $150M Series D in March 2026 and cumulative funding of about $328M. This capital appears to support expansion into insurers, employers, and health-system partnerships.

Market Expansion: Feedback suggests the company expanded distribution via 125+ health-plan partners (later 135), employer benefits, and health-system integrations. These channels appear to broaden reach beyond direct patient acquisition.

Strong Revenue Growth: Public disclosures indicate repeated high-growth recognition (e.g., Inc. 5000 and Deloitte) and that revenue more than doubled in fiscal 2022 alongside significant increases in transaction volume. Together with multi-year growth accolades, these signals point to a strong historical revenue trajectory.

Market Expansion: Contract announcements show continued expansion via new and renewed state engagements in 2024–2025, including Ohio’s selection for five scholarship programs and Indiana’s expanded agreement. Company materials also cite operations across dozens of states, millions of users, and a growing vendor network, indicating broader geographic and customer reach.

Investor Backing & Capital Strength: A $95 million growth-capital round in 2023 led by institutional investors is presented as supporting scaling of operations and technology. This funding underpins capacity to pursue additional contracts and expand the platform.

Strong Revenue Growth: Evidence points to ARR reaching about $210M with continued year-over-year increases, and company statements indicate surpassing $200M in annualized revenue. Feedback suggests upselling and higher average revenue per customer support expansion from existing accounts.

Market Expansion: Adoption reportedly grew from ~410 customers in 2020 to 1,200+ by 2024, with 240 new customers added in 2024 and penetration into top-50 global biopharma firms. Feedback suggests partnerships and geographic breadth bolster reach across biotech and pharma.

Innovation-Driven Growth: Product launches in AI, automation, and broader R&D workflows, plus acquisitions and collaborations (e.g., Lilly TuneLab, NVIDIA) indicate active investment in next-generation capabilities. Feedback suggests these moves expand use cases and deepen platform integration in labs.

Strong Revenue Growth: Reported annual revenue reached $100 million in 2025 and annual recurring revenue surpassed $200 million by late 2026, indicating accelerating top-line momentum. Growth was characterized as rapid during 2026, reflecting increased customer demand and scale.

Market Expansion: The company entered Canada with UnKibble and stepped up brand investment, including a multimillion-dollar TV and out-of-home campaign. These moves expand geographic reach and aim to scale acquisition beyond prior channels.

Product Line Growth: Offerings broadened beyond fresh meals and UnKibble into supplements and the PupGum dental-chew brand, which reportedly reached eight-figure recurring revenue within months of launch. Added categories and dedicated leadership signal a push to build a wider pet wellness platform.

Strong Market Position & Advantage: Strong Market Position & Advantage: Scale is described as more than 290–300 million learners and roughly 18,000 enterprise customers after the May 2026 combination, indicating extensive reach across consumer and enterprise learning. The combined catalog spans university-backed credentials and a large instructor marketplace, supporting broad coverage of professional skills and AI-focused training.

Cost & Operational Efficiency: Cost & Operational Efficiency: Guidance points to approximately $115 million in annual cost synergies within 24 months of closing and an adjusted EBITDA margin target of about 14% for 2026. Udemy’s return to positive GAAP net income in 2025 further indicates an improving profitability trajectory for the combined business.

Innovation-Driven Growth: Innovation-Driven Growth: AI-related learning is expanding rapidly, with Udemy reporting 120% growth in AI course enrollments and Coursera citing a 33% increase in micro-credential enrollments. Subscription-led offerings and professional certificates are highlighted as key drivers of engagement and recurring revenue.